These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35430131)

  • 1. Bone Health in Women With Polycystic Ovary Syndrome: A Narrative Review.
    Noroozzadeh M; Amiri M; Farhadi-Azar M; Ramezani Tehrani F
    J Clin Densitom; 2022; 25(4):606-614. PubMed ID: 35430131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications.
    Sun Y; Gao S; Ye C; Zhao W
    Front Cell Infect Microbiol; 2023; 13():1142041. PubMed ID: 36909735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 5. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
    Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
    Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis.
    Piovezan JM; Premaor MO; Comim FV
    Hum Reprod Update; 2019 Sep; 25(5):633-645. PubMed ID: 31374576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
    Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
    Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome.
    Çıtar Dazıroğlu ME; Acar Tek N
    Curr Nutr Rep; 2023 Mar; 12(1):191-202. PubMed ID: 36719550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota.
    Zhang M; Hu R; Huang Y; Zhou F; Li F; Liu Z; Geng Y; Dong H; Ma W; Song K; Song Y
    Front Endocrinol (Lausanne); 2022; 13():933110. PubMed ID: 35928893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
    Morgante G; Troìa L; De Leo V
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal alterations in PCOS and its influence on bone metabolism.
    Krishnan A; Muthusami S
    J Endocrinol; 2017 Feb; 232(2):R99-R113. PubMed ID: 27895088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
    Demi R İ; Guler A; Alarslan P; Isil AM; Ucman O; Aslanipour B; Calan M
    Endocrine; 2019 Jul; 65(1):175-183. PubMed ID: 31154608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota.
    Prakash A; Nourianpour M; Senok A; Atiomo W
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.